S&P 500   5,253.88 (+0.10%)
DOW   39,767.51 (+0.02%)
QQQ   444.87 (+0.01%)
AAPL   170.81 (-1.44%)
MSFT   420.69 (-0.18%)
META   489.70 (-0.84%)
GOOGL   150.41 (-0.30%)
AMZN   180.82 (+0.55%)
TSLA   176.92 (-1.62%)
NVDA   908.14 (+0.62%)
NIO   4.63 (-0.86%)
AMD   182.99 (+1.89%)
BABA   72.40 (+1.13%)
T   17.58 (+0.17%)
F   13.19 (+1.00%)
MU   118.42 (-0.60%)
CGC   9.11 (-4.61%)
GE   175.56 (-2.53%)
DIS   122.20 (+1.01%)
AMC   3.74 (-13.82%)
PFE   27.86 (+0.29%)
PYPL   66.94 (+0.56%)
XOM   115.40 (+0.37%)
S&P 500   5,253.88 (+0.10%)
DOW   39,767.51 (+0.02%)
QQQ   444.87 (+0.01%)
AAPL   170.81 (-1.44%)
MSFT   420.69 (-0.18%)
META   489.70 (-0.84%)
GOOGL   150.41 (-0.30%)
AMZN   180.82 (+0.55%)
TSLA   176.92 (-1.62%)
NVDA   908.14 (+0.62%)
NIO   4.63 (-0.86%)
AMD   182.99 (+1.89%)
BABA   72.40 (+1.13%)
T   17.58 (+0.17%)
F   13.19 (+1.00%)
MU   118.42 (-0.60%)
CGC   9.11 (-4.61%)
GE   175.56 (-2.53%)
DIS   122.20 (+1.01%)
AMC   3.74 (-13.82%)
PFE   27.86 (+0.29%)
PYPL   66.94 (+0.56%)
XOM   115.40 (+0.37%)
S&P 500   5,253.88 (+0.10%)
DOW   39,767.51 (+0.02%)
QQQ   444.87 (+0.01%)
AAPL   170.81 (-1.44%)
MSFT   420.69 (-0.18%)
META   489.70 (-0.84%)
GOOGL   150.41 (-0.30%)
AMZN   180.82 (+0.55%)
TSLA   176.92 (-1.62%)
NVDA   908.14 (+0.62%)
NIO   4.63 (-0.86%)
AMD   182.99 (+1.89%)
BABA   72.40 (+1.13%)
T   17.58 (+0.17%)
F   13.19 (+1.00%)
MU   118.42 (-0.60%)
CGC   9.11 (-4.61%)
GE   175.56 (-2.53%)
DIS   122.20 (+1.01%)
AMC   3.74 (-13.82%)
PFE   27.86 (+0.29%)
PYPL   66.94 (+0.56%)
XOM   115.40 (+0.37%)
S&P 500   5,253.88 (+0.10%)
DOW   39,767.51 (+0.02%)
QQQ   444.87 (+0.01%)
AAPL   170.81 (-1.44%)
MSFT   420.69 (-0.18%)
META   489.70 (-0.84%)
GOOGL   150.41 (-0.30%)
AMZN   180.82 (+0.55%)
TSLA   176.92 (-1.62%)
NVDA   908.14 (+0.62%)
NIO   4.63 (-0.86%)
AMD   182.99 (+1.89%)
BABA   72.40 (+1.13%)
T   17.58 (+0.17%)
F   13.19 (+1.00%)
MU   118.42 (-0.60%)
CGC   9.11 (-4.61%)
GE   175.56 (-2.53%)
DIS   122.20 (+1.01%)
AMC   3.74 (-13.82%)
PFE   27.86 (+0.29%)
PYPL   66.94 (+0.56%)
XOM   115.40 (+0.37%)
OTCMKTS:ARSUF

Fagron (ARSUF) Stock Price, News & Analysis

$18.59
0.00 (0.00%)
(As of 03/27/2024 ET)
Today's Range
$18.59
$18.59
50-Day Range
$18.06
$19.26
52-Week Range
$16.15
$19.26
Volume
N/A
Average Volume
3,287 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
2.90%
Price Target
N/A
ARSUF stock logo

About Fagron Stock (OTCMKTS:ARSUF)

Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, and patients worldwide. It operates in three segments: Essentials, Brands, and Compounding Services. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. Its products include DiluCap, a line of excipients to compound every capsule formulation; Imuno TF Complex helps in regulation of immune responses; Pigmerise, a natural phytocomplex for hypopigmentation disorders; Pentravan uses for avoiding first-pass metabolism and preventing gastrointestinal erosion; Nourisil MD, a first line therapy for prevention and treatment of scars ang keloids; Neogen, a line of hair care products; TrichoConcept used to treat alopecia; Fagron Advanced Derma for basic skincare, compound pharmaceutical treatment, and individualized dermatological care; and SyrSpend SF that provides pharmaceutical stability, dosage consistency, and patient comfort. In addition, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.

ARSUF Stock Price History

ARSUF Stock News Headlines

Fagron delivers topline growth of 21.5% to €173 million
Did You Get Your Free Bitcoin Yet?
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
Full year ‘21 results Fagron in line with expectations
See More Headlines
Receive ARSUF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fagron and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
OTCMKTS:ARSUF
CIK
N/A
Fax
N/A
Employees
3,035
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. Rafael Padilla (Age 46)
    CEO & Executive Director
    Comp: $708.91k
  • Ms. Karin de Jong (Age 45)
    CFO & Executive Director
    Comp: $1.09M
  • Ms. Vera Bakker (Age 52)
    Chief Operating Officer
    Comp: $8.17k
  • Karen Berg
    Global Investor Relations Manager
  • Mr. Johan Verlinden
    Head of Legal, Mergers & Acquisitions

ARSUF Stock Analysis - Frequently Asked Questions

How have ARSUF shares performed in 2024?

Fagron's stock was trading at $18.4794 at the start of the year. Since then, ARSUF shares have increased by 0.6% and is now trading at $18.5893.
View the best growth stocks for 2024 here
.

Is Fagron a good dividend stock?

Fagron (OTCMKTS:ARSUF) pays an annual dividend of $0.54 per share and currently has a dividend yield of 1.72%.

How do I buy shares of Fagron?

Shares of ARSUF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:ARSUF) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners